Market news
Detailed price information for Indaptus Therapeutics Inc (INDP-Q) from The Globe and Mail including charting and trades.
Indaptus Therapeutics (INDP) shares rose nearly 22% in Thursday afternoon trading after the company
NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company"), a biotechnology company dedicated to immunotherapy research, today announced financial results for the second quarter and six months ended June 30, 2026, and provided a corporate update. Junyi Dai, Indaptus Therapeutics' Chief Executive Officer and Chairman of the Board, commented, "During the second quarter, we strengthened the Company's balance sheet through a $12.0 million pri
This is the newest page. Registered accounts read further back.